Genetic Heterogeneity of Circulating Cells from Patients with Lymphangioleiomyomatosis with and without Lung Transplantation

This publication has 15 references indexed in Scilit:

• Sirolimus Decreases Circulating Lymphangioleiomyomatosis Cells in Patients With Lymphangioleiomyomatosis
  Chest, 2014
• Osteoprotegerin Contributes to the Metastatic Potential of Cells with a Dysfunctional TSC2 Tumor-Suppressor Gene
  The American Journal of Pathology, 2013
• Lymphangioleiomyomatosis: Calling It What It Is: A Low-Grade, Destructive, Metastasizing Neoplasm
  American Journal of Respiratory and Critical Care Medicine, 2012
• Lymphangioleiomyomatosis — a wolf in sheep’s clothing
  Journal of Clinical Investigation, 2012
• Cancer Dormancy: A Model of Early Dissemination and Late Cancer Recurrence
  Clinical Cancer Research, 2012
• Erythropoietin-driven proliferation of cells with mutations in the tumor suppressor geneTSC2
  American Journal of Physiology-Lung Cellular and Molecular Physiology, 2011
• Phenotypic Characterization of Disseminated Cells with TSC2 Loss of Heterozygosity in Patients with Lymphangioleiomyomatosis
  American Journal of Respiratory and Critical Care Medicine, 2010
• Tumor heterogeneity: Causes and consequences
  Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2010
• Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis
  Proceedings of the National Academy of Sciences, 2004
• Evidence That Lymphangiomyomatosis Is Caused by TSC2 Mutations: Chromosome 16p13 Loss of Heterozygosity in Angiomyolipomas and Lymph Nodes from Women with Lymphangiomyomatosis
  The American Journal of Human Genetics, 1998